NCT01536795View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Tolerance of WR279,396 for Old World Cutaneous Leishmaniasis

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Old World Cutaneous Leishmaniasis
Interventions
DRUG

WR279,396 with Tegaderm Dressing

Ointment containing paromomycin sulphate (15%) and gentamicin sulphate (0.5%) - in a base (AQIC)applied for 20 days with polyurethane dressing

DRUG

WR 279,396 with Gauze and Tape Dressing

Ointment containing paromomycin sulphate (15%) and gentamicin sulphate (0.5%) - in a base (AQIC)applied for 20 days

Trial Locations (1)

Unknown

Institut Pasteur, Tunis

All Listed Sponsors
lead

U.S. Army Medical Research and Development Command

FED

NCT01536795 - A Study to Evaluate the Efficacy and Tolerance of WR279,396 for Old World Cutaneous Leishmaniasis | Biotech Hunter | Biotech Hunter